SANDOZ INC FDA Approval ANDA 206080

ANDA 206080

SANDOZ INC

FDA Drug Application

Application #206080

Application Sponsors

ANDA 206080SANDOZ INC

Marketing Status

None (Tentative Approval)001

Application Products

001SOLUTION;OPHTHALMIC1.5%0BEPOTASTINE BESILATEBEPOTASTINE BESILATE

FDA Submissions

UNKNOWN; ORIG1TA2017-06-07STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

SANDOZ INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206080
            [companyName] => SANDOZ INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"BEPOTASTINE BESILATE","activeIngredients":"BEPOTASTINE BESILATE","strength":"1.5%","dosageForm":"SOLUTION;OPHTHALMIC","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/07\/2017","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-06-07
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.